ISSN: 2995-8067 | Quick Google Scholar
Organised by 
Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.
Our goal is to inspire a culture of interdisciplinary dialogue that drives faster innovation.
At IgMin Research, we offer a dedicated platform for publishing innovative work in drug metabolism—a crucial field in pharmacology and toxicology. If you're ready to submit research on drug metabolism, our journal ensures rapid peer review, expert guidance, and global reach.
Explore leading drug metabolism publishing platforms and become part of a thriving scientific community focused on improving therapeutic outcomes and drug safety.
Publishing with IgMin Research provides the visibility your research deserves—helping you make a real impact in the biomedical field.
Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.
Global Visibility – Indexed in major databases
Fast Peer Review – Decision within 14–21 days
Open Access – Maximize readership and citation
Multidisciplinary Scope – Biology, Medicine and Engineering
Editorial Board Excellence – Global experts involved
University Library Indexing – Via OCLC
Permanent Archiving – CrossRef DOI
APC – Affordable APCs with discounts
Citation – High Citation Potential
Which articles are now trending?
